Literature DB >> 35153270

Implications of glutathione-S transferase P1 in MAPK signaling as a CRAF chaperone: In memory of Dr. Irving Listowsky.

Yoshiro Niitsu1,2, Yasushi Sato3, Tetsuji Takayama3.   

Abstract

Glutathione-S transferase P1 (GSTP1) is one of the glutathione-S transferase isozymes that belong to a family of phase II metabolic isozymes. The unique feature of GSTP1 compared with other GST isozymes is its relatively high expression in malignant tissues. Thus, clinically, GSTP1 serves as a tumor marker and as a refractory factor against certain types of anticancer drugs through its primary function as a detoxifying enzyme. Additionally, recent studies have identified a chaperone activity of GSTP1 involved in the regulation the function of various intracellular proteins, including factors of the growth signaling pathway. In this review, we will first describe the function of GSTP1 and then extend the details onto its role in the mitogen-activated protein kinase signal pathway, referring to the results of our recent study that proposed a novel autocrine signal loop formed by the CRAF/GSTP1 complex in mutated KRAS and BRAF cancers. Finally, the possibilities of new therapeutic approaches for these cancers by targeting this complex will be discussed.

Entities:  

Keywords:  BRAF cancer; GSTP1; KRAS cancer; MAPK signaling; drug resistance; tumor marker

Mesh:

Substances:

Year:  2022        PMID: 35153270      PMCID: PMC8890996          DOI: 10.2183/pjab.98.005

Source DB:  PubMed          Journal:  Proc Jpn Acad Ser B Phys Biol Sci        ISSN: 0386-2208            Impact factor:   3.493


  80 in total

1.  Targeting GSTP1-1 induces JNK activation and leads to apoptosis in cisplatin-sensitive and -resistant human osteosarcoma cell lines.

Authors:  Andrea Sau; Giuseppe Filomeni; Silvia Pezzola; Simona D'Aguanno; Francesca Pellizzari Tregno; Andrea Urbani; Massimo Serra; Michela Pasello; Piero Picci; Giorgio Federici; Anna Maria Caccuri
Journal:  Mol Biosyst       Date:  2011-11-09

Review 2.  Glutathione transferases: a structural perspective.

Authors:  Aaron Oakley
Journal:  Drug Metab Rev       Date:  2011-03-23       Impact factor: 4.518

Review 3.  MEK inhibitor resistance mechanisms and recent developments in combination trials.

Authors:  E Kun; Y T M Tsang; C W Ng; D M Gershenson; K K Wong
Journal:  Cancer Treat Rev       Date:  2020-12-16       Impact factor: 12.111

4.  Potent anti-proliferative actions of a non-diuretic glucosamine derivative of ethacrynic acid.

Authors:  Surendra R Punganuru; A G M Mostofa; Hanumantha Rao Madala; Debasish Basak; Kalkunte S Srivenugopal
Journal:  Bioorg Med Chem Lett       Date:  2016-04-22       Impact factor: 2.823

5.  Phosphorylation of Glutathione S-Transferase P1 (GSTP1) by Epidermal Growth Factor Receptor (EGFR) Promotes Formation of the GSTP1-c-Jun N-terminal kinase (JNK) Complex and Suppresses JNK Downstream Signaling and Apoptosis in Brain Tumor Cells.

Authors:  Tatsunori Okamura; Gamil Antoun; Stephen T Keir; Henry Friedman; Darell D Bigner; Francis Ali-Osman
Journal:  J Biol Chem       Date:  2015-10-01       Impact factor: 5.157

6.  Randomized double-blind trial of sulindac and etodolac to eradicate aberrant crypt foci and to prevent sporadic colorectal polyps.

Authors:  Tetsuji Takayama; Hiroyuki Nagashima; Masahiro Maeda; Shuichi Nojiri; Michiaki Hirayama; Yoichiro Nakano; Yasuo Takahashi; Yasushi Sato; Hitoshi Sekikawa; Mitsuru Mori; Tomoko Sonoda; Tetsuo Kimura; Junji Kato; Yoshiro Niitsu
Journal:  Clin Cancer Res       Date:  2011-03-08       Impact factor: 12.531

7.  Organic anion-binding protein in rat liver: drug induction and its physiologic consequence.

Authors:  H Reyes; A J Levi; Z Gatmaitan; I M Arias
Journal:  Proc Natl Acad Sci U S A       Date:  1969-09       Impact factor: 11.205

8.  Glutathione transferase pi plays a critical role in the development of lung carcinogenesis following exposure to tobacco-related carcinogens and urethane.

Authors:  Kenneth J Ritchie; Colin J Henderson; Xiu Jun Wang; Olga Vassieva; Dianne Carrie; Peter B Farmer; Margaret Gaskell; Kevin Park; C Roland Wolf
Journal:  Cancer Res       Date:  2007-10-01       Impact factor: 12.701

9.  Decreased expression of GST pi is correlated with a poor prognosis in human esophageal squamous carcinoma.

Authors:  Zhihui Wang; Wei He; Guanrui Yang; Junsheng Wang; Zhong Wang; Jahn M Nesland; Ruth Holm; Zhenhe Suo
Journal:  BMC Cancer       Date:  2010-07-05       Impact factor: 4.430

Review 10.  Recent advances in the development of protein-protein interactions modulators: mechanisms and clinical trials.

Authors:  Haiying Lu; Qiaodan Zhou; Jun He; Zhongliang Jiang; Cheng Peng; Rongsheng Tong; Jianyou Shi
Journal:  Signal Transduct Target Ther       Date:  2020-09-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.